Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A

J Clin Virol. 2019 Feb:111:12-18. doi: 10.1016/j.jcv.2018.12.007. Epub 2018 Dec 19.

Abstract

Background: Assessment of human immunodeficiency virus type 1 (HIV-1) coreceptor usage is required prior to treatment with the CCR5 antagonist maraviroc to exclude the presence of CXCR4-using (X4) strains. Genotype-based interpretation systems are mostly designed on subtype B and have been reported to be less accurate for subtype A/CRF02_AG.

Objectives: To evaluate the performance of the widely used Geno2Pheno[coreceptor] (G2P[c]) algorithm for prediction of coreceptor usage with subtype A/CRF02_AG vs. subtype B.

Study design: Co-receptor tropism of 24 subtype A/CRF02_AG and 24 subtype B viruses was measured phenotypically by a homebrew single-cycle assay and genotypically by using G2P[c]. Samples with discrepant genotype-phenotype results were analyzed by next generation sequencing (NGS) and interpreted by the NGS Geno2Pheno algorithm (G2P[454]).

Results: At 10% false positive rate (FPR), the G2P[c]/phenotype discordance rate was 12.5% (n = 3) for subtype A/CRF02_AG and 8.3% (n = 2) for subtype B. Minority X4 species escaping detection by bulk sequencing but documented by NGS explained the two subtype B and possibly one subtype A/CRF02_AG discordant case. The other two subtype A/CRF02_AG miscalled by G2P[c] could be explained by X4 overcalling at borderline FPR and/or by algorithm failure.

Discussion: Our study did not demonstrate relevantly higher G2P[c] inaccuracy with subtype A/CRF02_AG with respect to subtype B. Genotype/phenotype discordances can be due to different reasons, including but not limited to, algorithm inaccuracy. Very large genotype/phenotype correlation panels are required to detect and explain the reason for any consistent difference in genotypic tropism prediction for subtype A/CRF02_AG vs. subtype B.

Keywords: Coreceptor usage; Genotype; HIV-1 tropism; NGS; Phenotype; Subtype A.

Publication types

  • Evaluation Study

MeSH terms

  • Algorithms*
  • CCR5 Receptor Antagonists / therapeutic use
  • Genotype
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV-1 / genetics*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Maraviroc / therapeutic use
  • Phenotype
  • Receptors, HIV / classification
  • Receptors, HIV / genetics*
  • Software
  • Viral Tropism*
  • Viremia

Substances

  • CCR5 Receptor Antagonists
  • Receptors, HIV
  • Maraviroc